TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express

03/13

TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.

At the session, directors will: 1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited. 2. Deliberate on the declaration of a final dividend, if any. 3. Consider closure dates for the register of shareholders, if required. 4. Determine the time, venue, and agenda of the forthcoming annual general meeting. 5. Address any additional matters placed before the Board.

The notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1101353774"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1101353774\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1101353774?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101353774","market":"us","top_or_hot":-1,"title":"TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal","media":"Bulletin Express","content":"<p>TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.</p>\n<p>At the session, directors will:\n1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited.\n2. Deliberate on the declaration of a final dividend, if any.\n3. Consider closure dates for the register of shareholders, if required.\n4. Determine the time, venue, and agenda of the forthcoming annual general meeting.\n5. Address any additional matters placed before the Board.</p>\n<p>The notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTEDA Biomedical (08189) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-13 19:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.</p>\n<p>At the session, directors will:\n1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited.\n2. Deliberate on the declaration of a final dividend, if any.\n3. Consider closure dates for the register of shareholders, if required.\n4. Determine the time, venue, and agenda of the forthcoming annual general meeting.\n5. Address any additional matters placed before the Board.</p>\n<p>The notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08189","symbol_name":"泰達生物","start_time":0,"source_url":"","article_id":"1101353774","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101353774","pubTimestamp":1773399631,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08189":"泰达生物"},"translate_title":"泰达生物医药(08189)定于2026年3月31日召开董事会批准2025财年业绩及股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08189":1},"content_text":"TEDA Biomedical Engineering Company Limited (stock code: 08189) will convene a board meeting on 31 March 2026 (Tuesday) at 10:00 a.m. on the 9th Floor, Block A2, Tianda High-Tech Park, No. 80 The 4th Avenue, TEDA, Tianjin, the People’s Republic of China.\nAt the session, directors will:\n1. Review and approve the audited consolidated financial statements of the Group for the year ended 31 December 2025 and the related final results announcement for publication on the GEM website of The Stock Exchange of Hong Kong Limited.\n2. Deliberate on the declaration of a final dividend, if any.\n3. Consider closure dates for the register of shareholders, if required.\n4. Determine the time, venue, and agenda of the forthcoming annual general meeting.\n5. Address any additional matters placed before the Board.\nThe notice was authorised by Chairperson Sun Li and released on 13 March 2026 in Tianjin, PRC. The Board currently comprises three executive directors, three non-executive directors, and three independent non-executive directors, whose names are detailed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}